161 related articles for article (PubMed ID: 37105678)
1. Associating
Halilibrahimoğlu H; Polat K; Keskin S; Genç O; Aslan O; Öztürk-Işık E; Yakıcıer C; Danyeli AE; Pamir MN; Özduman K; Dinçer A; Özcan A
AJNR Am J Neuroradiol; 2023 May; 44(5):553-561. PubMed ID: 37105678
[TBL] [Abstract][Full Text] [Related]
2. Diffusion Tensor Imaging Reveals Microstructural Heterogeneity of Normal-Appearing White Matter and Related Cognitive Dysfunction in Glioma Patients.
Jütten K; Mainz V; Gauggel S; Patel HJ; Binkofski F; Wiesmann M; Clusmann H; Na CH
Front Oncol; 2019; 9():536. PubMed ID: 31293974
[TBL] [Abstract][Full Text] [Related]
3. Molecular Subtype Classification in Lower-Grade Glioma with Accelerated DTI.
Aliotta E; Nourzadeh H; Batchala PP; Schiff D; Lopes MB; Druzgal JT; Mukherjee S; Patel SH
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1458-1463. PubMed ID: 31413006
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.
Xu Z; Ke C; Liu J; Xu S; Han L; Yang Y; Qian L; Liu X; Zheng H; Lv X; Wu Y
Eur J Radiol; 2021 Jan; 134():109466. PubMed ID: 33307459
[TBL] [Abstract][Full Text] [Related]
5. Mean apparent propagator-MRI in evaluation of glioma grade, cellular proliferation, and IDH-1 gene mutation status.
Sun Y; Su C; Deng K; Hu X; Xue Y; Jiang R
Eur Radiol; 2022 Jun; 32(6):3744-3754. PubMed ID: 35076759
[TBL] [Abstract][Full Text] [Related]
6. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
[TBL] [Abstract][Full Text] [Related]
7. A correlation between diffusion kurtosis imaging and the proliferative activity of brain glioma.
Tonoyan AS; Pronin IN; Pitshelauri DI; Shishkina LV; Fadeeva LM; Pogosbekyan EL; Zakharova NE; Shults EI; Khachanova NV; Kornienko VN; Potapov AA
Zh Vopr Neirokhir Im N N Burdenko; 2015; 79(6):5-14. PubMed ID: 26977789
[TBL] [Abstract][Full Text] [Related]
8. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract][Full Text] [Related]
9. Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.
Kong Z; Zhang Y; Liu D; Liu P; Shi Y; Wang Y; Zhao D; Cheng X; Wang Y; Ma W
Ann Nucl Med; 2021 Apr; 35(4):493-503. PubMed ID: 33532992
[TBL] [Abstract][Full Text] [Related]
10. Value of diffusion kurtosis imaging in assessing low-grade gliomas.
Goryawala MZ; Heros DO; Komotar RJ; Sheriff S; Saraf-Lavi E; Maudsley AA
J Magn Reson Imaging; 2018 Dec; 48(6):1551-1558. PubMed ID: 29573042
[TBL] [Abstract][Full Text] [Related]
11. Apparent Diffusion Coefficient as Imaging Biomarker for Identifying IDH Mutation, 1p19q Codeletion, and MGMT Promoter Methylation Status in Patients With Glioma.
Ma X; Cheng K; Cheng G; Li C; Lyu J; Lan Y; Duan C; Bian X; Zhang J; Lou X
J Magn Reson Imaging; 2023 Sep; 58(3):732-738. PubMed ID: 36594577
[TBL] [Abstract][Full Text] [Related]
12. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Chan AK; Park CK; Fung KM; Hassell L
Crit Rev Oncol Hematol; 2017 Dec; 120():1-9. PubMed ID: 29198322
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging, clinical and life course correlates of normal-appearing white matter integrity in 70-year-olds.
James SN; Manning EN; Storey M; Nicholas JM; Coath W; Keuss SE; Cash DM; Lane CA; Parker T; Keshavan A; Buchanan SM; Wagen A; Harris M; Malone I; Lu K; Needham LP; Street R; Thomas D; Dickson J; Murray-Smith H; Wong A; Freiberger T; Crutch SJ; Fox NC; Richards M; Barkhof F; Sudre CH; Barnes J; Schott JM
Brain Commun; 2023; 5(5):fcad225. PubMed ID: 37680671
[TBL] [Abstract][Full Text] [Related]
14. Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain.
Hughes M; Sundgren PC; Fan X; Foerster B; Nan B; Welsh RC; Williamson JA; Attwood J; Maly PV; Chenevert TL; McCune W; Gebarski S
Acta Radiol; 2007 Mar; 48(2):213-22. PubMed ID: 17354144
[TBL] [Abstract][Full Text] [Related]
15. Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients.
Regnery S; Behl NGR; Platt T; Weinfurtner N; Windisch P; Deike-Hofmann K; Sahm F; Bendszus M; Debus J; Ladd ME; Schlemmer HP; Rieken S; Adeberg S; Paech D
Neuroimage Clin; 2020; 28():102427. PubMed ID: 33002860
[TBL] [Abstract][Full Text] [Related]
16. Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci.
Labreche K; Kinnersley B; Berzero G; Di Stefano AL; Rahimian A; Detrait I; Marie Y; Grenier-Boley B; Hoang-Xuan K; Delattre JY; Idbaih A; Houlston RS; Sanson M
Acta Neuropathol; 2018 May; 135(5):743-755. PubMed ID: 29460007
[TBL] [Abstract][Full Text] [Related]
17. Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging.
Li S; Zheng Y; Sun W; Lasič S; Szczepankiewicz F; Wei Q; Han S; Zhang S; Zhong X; Wang L; Li H; Cai Y; Xu D; Li Z; He Q; van Westen D; Bryskhe K; Topgaard D; Xu H
Eur Radiol; 2021 Nov; 31(11):8197-8207. PubMed ID: 33914116
[TBL] [Abstract][Full Text] [Related]
18. The timing of stereotactic radiosurgery for medically refractory trigeminal neuralgia: the evidence from diffusion tractography images.
Lee CC; Chong ST; Chen CJ; Hung SC; Yang HC; Lin CJ; Wu CC; Chung WY; Guo WY; Pan DH; Wu HM; Sheehan JP; Lin CP
Acta Neurochir (Wien); 2018 May; 160(5):977-986. PubMed ID: 29397449
[TBL] [Abstract][Full Text] [Related]
19. TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas.
Zhang ZY; Chan AK; Ding XJ; Qin ZY; Hong CS; Chen LC; Zhang X; Zhao FP; Wang Y; Wang Y; Zhou LF; Zhuang Z; Ng HK; Yan H; Yao Y; Mao Y
Oncotarget; 2015 Sep; 6(28):24871-83. PubMed ID: 26314843
[TBL] [Abstract][Full Text] [Related]
20. Altered white matter integrity in patients with monocular blindness: A diffusion tensor imaging and tract-based spatial statistics study.
Liu YX; Li B; Wu KR; Tang LY; Lin Q; Li QH; Yuan Q; Shi WQ; Liang RB; Ge QM; Shao Y
Brain Behav; 2020 Aug; 10(8):e01720. PubMed ID: 32558355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
